FOUNTAIN HILLS, Ariz.,
Dec. 8, 2010 /PRNewswire-FirstCall/
-- Sunridge International (OTC Bulletin Board: SNDZ), announced
today that Ameco Medical is preparing to start the short term
clinical trials needed for reimbursement approval.
Ameco Medical Equipment L.L.C., Sunridge's exclusive distributor
for several Middle Eastern countries, has invited Dr. Leo D. Bores, Sunridge's medical consultant, to
attend the start of their clinical trials. Dr. Bores would be
traveling to multiple countries in the Middle East to work with key opinion leaders
at some of the largest hospitals and clinics in the region.
The purpose of the study will be to achieve reimbursement
approval for the PNT procedure throughout the area.
Sunridge International's CEO, G. Richard
Smith states, "We strive to have a close working
relationship with our distributors so that we can assist them when
needed in order to obtain success. Once reimbursement is
established, the tens of thousands of glaucoma sufferers can avail
themselves of this non-invasive treatment."
Glaucoma is the second leading cause of blindness, affecting
over 70 million people worldwide. PNT has been proven (through
studies completed over the last 10 yrs) to be a safe, effective,
non-invasive and cost effective alternative for treatment for
glaucoma and ocular hypertension. The 2-minute treatment has been
developed, patented, and distributed by Sunridge International,
wholly owned subsidiary, Ophthalmic International
www.oi-pnt.com.
|
CONTACT:
|
|
|
Jeff Smith,
Sunridge International
|
|
|
T:
+1-480-837-6165
|
|
|
e-mail:
info@sunridgeint.com
|
|
|
|
|
MEDIA:
|
|
|
Victor Webb,
Marston Webb International
|
|
|
T: (212)
684-6601
|
|
|
e-mail:
marwebint@cs.com
|
|
|
SOURCE Sunridge International
